Series A financing co-led by Balyasny Asset Management, venBio, and Janus Henderson InvestorsRugonersen, a potentially best-in-class antisense ...
First quarter total revenue of $136 million, Crysvita® revenue of $93 million and Dojolvi® revenue of $18 millionReaffirm 2026 financial ...
If you’re living with Lambert-Eaton myasthenic syndrome (LEMS), you probably already know that muscle weakness is one of the most common symptoms. It may even be what sent you to the doctor in the ...
Forbes contributors publish independent expert analyses and insights. Melissa Houston covers financial issues that affect women in business. This voice experience is generated by AI. Learn more. This ...
The event centers around Immy, a young Westlake girl living with Angelman Syndrome, a rare neurogenetic disorder that affects approximately 1 in 15,000 people. Characterized by developmental delays, ...
As it kicks off a pivotal phase 3 trial of its investigational treatment for Angelman syndrome (AS), Ionis Pharmaceuticals is laying the groundwork for a potential launch. After spending the last ...
ORLANDO, Fla. (Ivanhoe Newswire) - Parkinson’s is the most common motor disorder affecting almost 10 million people worldwide. It can cause debilitating symptoms like shaking, tremors, balance issues, ...
Panelists discuss how negative symptoms like lack of motivation, social withdrawal, and impaired expression significantly impact patients’ ability to maintain relationships and employment, ...
Goldman Sachs opened the gates to its upper ranks on Thursday, naming 638 new managing directors in one of Wall Street's most anticipated promotion rounds. The number represents a roughly 5% increase ...
October is National Menopause Awareness Month. Menopause remains widely misunderstood, and its impact is often dismissed or overlooked. The National Menopause Foundation is highlighting the importance ...
You’re managing more people than ever with far less support. Responsibilities keep multiplying, but the resources haven’t. And even though you’re supposed to be thinking strategically and focusing on ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ION582 for the treatment of Angelman ...